Supplement Industry Self-Regulation

Has Industry Self-Regulation Been Effective? 

Supplement industry self-regulation has helped in limited ways, but it has not been sufficient to ensure reliable safety. 

What has worked 

Voluntary GMP certifications (e.g., NSF, USP, Informed Choice) 

A minority of responsible supplement companies pursue third-party certification, which requires validated ingredient testing, supplier qualification, manufacturing audits, contaminant screening, and traceability documentation. 

These programs absolutely improve product consistency and reduce risk within the companies that use them. 

Published standards 

Trade organizations like AHPA (American Herbal Products Association), CRN (Council for Responsible Nutrition), and NPA (Natural Products Association) have developed voluntary guidelines for identity testing, raw material specifications, handling of botanicals, and GMP compliance. 

These documents can help responsible manufacturers operate at higher levels than DSHEA requires. 

The impact is limited and mostly optional 

The core problem is that the companies that most need oversight are the least likely to adopt voluntary standards. 

For the supplement industry, it includes ultra-low-cost contract manufacturers, Amazon microbrands with no in-house quality staff, overseas suppliers selling bulk powders with minimal testing, private-label brands without traceability, and companies on marketplaces for only 6–12 months. 

Self-regulation only works if you want to follow it. And DSHEA does not force low-tier companies to comply. 

The best companies follow high standards. The worst companies follow none. This is the opposite of what a safety-critical market should rely on. 

Key limitations of self-regulation 

It is voluntary. No one can force a company to adopt NSF/USP standards or trade-association guidelines. 

It does not cover the entire supply chain. Even good companies often rely on suppliers with limited testing, poor documentation, and inadequate sanitation controls. 

It does not fix foreign supplier vulnerabilities. Most botanical adulteration problems start overseas – outside the reach of U.S. trade groups. 

It does not enable full traceability. Self-regulation rarely requires serialized lots, downstream tracking, recall audits, or supply-chain transparency. 

It does not help the consumer identify safe companies. A typical consumer cannot easily distinguish the difference between a GMP-certified supplement, a non-certified but compliant supplement, a noncompliant supplement, an untested internet product, or a fraudulent formula. 

Because the labels look the same. 

When contamination breaks through, self-regulation collapses 

Every major outbreak tied to supplements in the last 20 years – Salmonella in kratom, turmeric, moringa, ashwagandha, and others – shows the same pattern. 

A contaminated ingredient originates overseas and gets blended into multiple products. Downstream companies do not test their ingredients or final product, and recalls are partial or delayed. And consumers are the last to know. 

Self-regulation did not prevent any of these events, nor did it ensure rapid detection or complete recall. 

How to best understand it 

Responsible companies have raised the floor for themselves. But the system has not raised the floor for everyone. 

DSHEA allows huge variability in quality, from companies that follow pharmaceutical-level controls to companies that do almost nothing beyond basic labeling. 

Self-regulation only lifts the top performers. It does not pull the bottom performers up.
And it does not remove unsafe actors from the market. 

So, finally, has industry self-regulation been effective? 

Partially, for some, but not enough. Not systemically and not reliably. 

The U.S. supplement market is now too large, too global, and too complex to rely on voluntary compliance. The moringa outbreak makes this painfully clear.